Inquiry into the Therapeutic Goods Amendment (Pharmaceutical
Transparency) Bill 2013
Public Hearings - Melbourne, Monday 29 April 2013
Time: 9.00 - 12.45
Venue: Conference Room Mantra 1
Mantra on Russell
222 Russell Street
Melbourne
9.00 am - 9.40 am |
Dr Ken Harvey (Sub 4)
Adjunct Associate Professor
School of Public Health, La Trobe University |
9.40 am - 10.20 am |
Australia Medical Association (Sub 7)
(via teleconference )
Dr Steve Hambleton, President |
10.20 am - 11.00 am |
GlaxoSmithKline (Sub 17)
Ms Lisa Maguire, Associate Director of Corporate Affairs |
11.00 am - 11.15 am |
Break |
11.15 am - 12.00 pm |
Medicines Australia (Sub 16)
Ms Deborah Monk, Director Innovation
Dr Dominic Barnes, Board Member |
12.00 pm - 12.45 pm |
Department of Health and Ageing (Sub 24)
Mr Peter Woodley, Assistant Secretary, Blood, organ and regulatory policy branch
Ms Philippa Horner PSM, Principal Legal Adviser, Therapeutic Goods Administration |
For further information, contact:
Committee Secretary
Senate Standing Committees on Finance and Public Administration
PO Box 6100
Parliament House
Canberra ACT 2600
Australia